期刊文献+

临床药师要用药学知识参与临床合理用药 被引量:4

Participation in rational use of drugs of clinical pharmacists with pharmaceutical knowledge
暂未订购
导出
摘要 一例肺癌术后复发病人拟口服盐酸厄洛替尼片进行化疗,该药由CYP3A4酶代谢,当与CYP3A4酶的抑制剂或诱导剂联合应用时,应适当调整盐酸厄洛替尼的剂量。该病人同时合并使用了其他6种药物,临床医师就此问题咨询临床药师,临床药师查询资料后给予解答,并由此引发了作者对临床药学工作的思考:临床药师在临床工作中是有用武之地的,但是必须要注重自身专业能力的提高。同时作者发现,国内临床用药的参考资料,如药品说明书和专著的内容有待更新和完善。 One patient with lung cancer recurrence after operation was given erlotinib hydrochloride tablet that was me- tabolised by CYP3A4 enzyme. When erlotinib hydrochloride was combinated with the inhibitor or inducer of CYP3A4 enzyme, its dosage should be properly adjusted. As the patient was given other six drugs at the same time, clincal doctor asked clinical pharmacist how to adjust the dosage of erlotinib hydrochloride. Clinical pharmacist answered the question after referring to doc- ument. The author thought that clinical pharmacists could play an important role in clinical work by improving the professional ability. Meanwhile, the author found that document about the use of drugs in domestic, such as package insert and monograph should be updated and improved.
出处 《药学服务与研究》 CAS CSCD 2012年第2期111-113,共3页 Pharmaceutical Care and Research
关键词 临床药师 药物相互作用 合理用药 药学服务 clinical pharmacist drug interactions rational use of drugs pharmaceutical care
  • 相关文献

参考文献3

二级参考文献15

  • 1李德淳.细胞色素P450酶系统在中医药研究中的应用[J].天津中医学院学报,1994,13(1):39-39. 被引量:11
  • 2Dean JO.美国临床药学发展[J].第9届全国高等药学教育研讨会,2000,10.
  • 3KALGUTKAR A S,GARDNER I,OBACH R S,et al.A comprehensive listing of bioactivation pathways of organic functional groups[J].Curr Drug Metab,2005,6(3):161-225.
  • 4CAZZOLA M,MATERA M G,LOTVALL J.Ultralongacting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease[J].Expert Opin Investig Drugs,2005,14(7):775-783.
  • 5RAATIKAINEN M J,NAPOLITANO C A,DRUZGALA P,et al.Electrophysiological effects of a novel short-acting and potent ester derivative of amiodarone,ATI-2001,in guinea pig isolated heart[J].J Pharmacol Exp Ther,1996,227(3):1454-1463.
  • 6FURA A,SHU Y Z,ZHU M,et al.Discovering drugs through biological transformation:role of pharmacologically active metabolites in drug discovery[J].J Med Chem,2004,47(18):4339-4351.
  • 7MATSUNAGA Y,HAMADA A,OKAMOTO I,et al.Pharmacokinetics of amrubicin with its active metabolite amrubicinol in lung cancer patients[J].Ther Drug Monit,2006,28(1):76-82.
  • 8MAGGS J L,WILLIAMS D,PIRMOHAMED M,et al.The metabolic formation of reactive intermediates from clozapine,a drug associated with agranulocytosis in man[J].J Pharmacol Exp Ther,1995,275(3):1463-1475.
  • 9David Josephy P.The molecular toxicology of acetaminophen[J].Drug Metab Rev,2005,37(4):581-594.
  • 10CALLAWAY J C,AIRAKSINEN MM,SALMELA K S,etal.Formation of tetrahydroharman (1-methyl-1,2,3,4-tetra-hydro-beta-carboline) by helicobacter pylori in the presence of ethanol and tryptamine[J].Life Sci,1996,58(21):1817-1821.

共引文献30

同被引文献29

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部